The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The High Throughput Screening (HTS) Market From 2026 To 2030?
The high throughput screening (hts) market size has experienced significant expansion in recent years. It is forecast to rise from $25.26 billion in 2025 to $27.47 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. This growth in prior periods stemmed from factors such as increasing demand for rapid drug discovery, advancements in assay technologies, growth in pharmaceutical R&D investments, rising adoption of robotics in laboratories, and the expansion of contract research organizations.
The high throughput screening (hts) market size is anticipated to experience substantial growth in the upcoming years, projected to reach $38.34 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is driven by factors such as the integration of AI and machine learning into hts, the advancement of personalized medicine, increased investments in biotechnology startups, the broadening of emerging markets in Asia-Pacific, and the innovation in multiplexed and label-free assay technologies. Prominent trends expected in this period encompass high-throughput automation integration, the miniaturization of screening platforms, sophisticated detection technologies, the development of multiplexed assays, and cloud-based data management.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp
Which Key Drivers Are Affecting The High Throughput Screening (HTS) Market Development?
The increasing incidence of chronic illnesses is anticipated to propel the expansion of the high-throughput screening (HTS) market moving forward. A chronic disease is defined as a health ailment or condition that endures for an extended duration, generally three months or longer. HTS facilitates the swift examination of many chemical compounds to identify promising drug candidates that target particular pathways or mechanisms involved in chronic diseases, which is crucial for managing them effectively over the long term. As an illustration, the National Library of Medicine, a US-based government agency, reported in January 2023 that the population in the US aged 50 and older with at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the expanding prevalence of chronic diseases will stimulate the growth of the high-throughput screening (HTS) market.
What Segment Categories Shape The High Throughput Screening (HTS) Market Segment Landscape?
The high throughput screening (hts) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
Subsegments:
1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents
2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices
3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services
Which Trends Are Contributing To Changes In The High Throughput Screening (HTS) Market?
Leading companies in the high-throughput screening market are developing innovative products, such as multimode plate readers, to better serve their customers with advanced functionalities. A multimode plate reader (MPR) is a sophisticated laboratory instrument utilized in high-throughput screening for analyzing biological and chemical samples within microplates, achieved by integrating multiple detection modes for diverse assays onto a single platform. For instance, in February 2023, PerkinElmer Inc., a US-based MedTech company, introduced the EnVision Nexus system. This system is noted as the fastest and most sensitive multimode plate reader available, specifically engineered for demanding high-throughput screening (HTS) applications to expedite drug discovery efforts. Through its unique technology, which includes dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, along with the latest reagent kits, the platform offers researchers exceptional assay flexibility, accuracy, speed, and sensitivity. Equipped with walkaway convenience options such as a plate stacker for 20 or 50 plates or full automation and integration for continuous 24/7 workflow operations, the EnVision Nexus system enables researchers to efficiently screen millions of samples with remarkable efficiency.
Who Are The Companies Operating Across The High Throughput Screening (HTS) Market Value Chain?
Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.
Get The Full High Throughput Screening (HTS) Market Report:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Where Is The High Throughput Screening (HTS) Market Primarily Concentrated By Region?
North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized High Throughput Screening (HTS) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company
High Throughput Screening Hts Market Report 2026
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Carrier Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report
Herg Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model